# ANAVEX LIFE SCIENCES CORP. (AVXL) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1314052 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/AVXL) · [JSON](https://www.pops4.com/boards/company/AVXL.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-05-22 ([filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm))
- Item NT 10-Q Late quarterly report notice: 2, latest 2026-08-10 ([filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001031/0001731122-26-001031-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001395/0001731122-26-001395-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001395/0001731122-26-001395-index.htm)
- 8-K · filed 2026-11-02 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001392/0001731122-26-001392-index.htm)
- 8-K · filed 2026-10-20 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001351/0001731122-26-001351-index.htm)
- 8-K · filed 2026-10-15 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001348/0001731122-26-001348-index.htm)
- 8-K · filed 2026-09-28 · 5.01 Changes in Control of Registrant; 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001294/0001731122-26-001294-index.htm)
- 8-K · filed 2026-09-09 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1314052/000173112226001211/0001731122-26-001211-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001314052.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1314052

## Cite

POPS4, Edgar & Edgarette: ANAVEX LIFE SCIENCES CORP. (AVXL) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/AVXL. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.